Detalhe da pesquisa
1.
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Gastroenterology
; 155(2): 479-489.e7, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655834
2.
Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
Oncology
; 94 Suppl 1: 6-9, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30036862
3.
Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.
Neuroendocrinology
; 106(4): 307-311, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743120
4.
Osteopontin, E-cadherin, and ß-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.
Gastric Cancer
; 19(2): 412-420, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862567
5.
Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.
Cancer
; 120(16): 2457-63, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752410
6.
Safety profile and treatment response of everolimus in different solid tumors: an observational study.
Future Oncol
; 10(9): 1611-7, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145431
7.
Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study.
Oncologist
; 18(1): 46-53, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23263288
8.
Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials.
Support Care Cancer
; 21(2): 565-73, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869054
9.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
Lancet Oncol
; 13(12): 1225-33, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23168362
10.
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.
J Clin Oncol
; 41(33): 5118-5130, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556775
11.
Palonosetron plus 1-day dexamethasone for the prevention of nausea and vomiting due to moderately emetogenic chemotherapy: effect of established risk factors on treatment outcome in a phase III trial.
J Support Oncol
; 10(2): 65-71, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22005217
12.
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors.
JAMA Netw Open
; 5(2): e220290, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201309
13.
Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial.
BJU Int
; 107(2): 214-9, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20942831
14.
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration.
BJU Int
; 108(2): 223-7, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21078047
15.
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases.
BJU Int
; 108(8 Pt 2): E250-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21599821
16.
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.
Support Care Cancer
; 19(8): 1217-25, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20574663
17.
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
Lancet
; 373(9674): 1525-31, 2009 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19410716
18.
Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.
Tumori
; 96(1): 154-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20437874
19.
An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.
Tumori
; 96(6): 1031-4, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388071
20.
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study.
Lancet
; 371(9630): 2101-8, 2008 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18514303